Part-Time OTA — Mon-Fri Growth & Benefits

Legacy Healthcare Services, Inc.; South Carolina; On-site; USD 34,000 - 50,000; Part time

Benefits offered by this job

401(k)

Medical/dental/vision/prescription/pet

Paid time off with rollover

Company-paid group life

Flex spending account

Disability insurance

Licensure reimbursement

CEUs and unlimited online CEUs

Career advancement opportunities

GROW bonus opportunity

Job summary

Legacy Healthcare Services, Inc. is seeking a part-time Occupational Therapy Assistant (COTA/OTA) to join our on-site rehabilitation team serving senior residents.

You will deliver one-on-one therapy, collaborate with a multidisciplinary team, and help patients achieve functional goals in a compassionate, patient-centered environment. We offer mentors, modern therapies, and opportunities to advance clinically.

Qualifications

• Associates degree required in occupational therapy or related field.
• Current OT assistant license in state of practice, or ability to obtain before starting.
• Excellent interpersonal, fiscal, and clinical skills.
• Computer proficiency required.

Responsibilities

• Assist with rehabilitative services for patients under medical orders as part of a coordinated on-site team.
• Provide one-on-one therapy services with a holistic, patient-centered approach.
• Receive mentorship and hands-on experience with innovative therapies and technologies.
• Support career growth and clinical specialization within the team.

Skills

Excellent interpersonal skills

Clinical skills

Computer proficiency

Education

Associates of applied science degree in area of discipline

Tools

Computer proficiency

Job description

Legacy Healthcare Services, Inc. is seeking a part-time Occupational Therapy Assistant (COTA/OTA) to join our on-site rehabilitation team serving senior residents.

You will deliver one-on-one therapy, collaborate with a multidisciplinary team, and help patients achieve functional goals in a compassionate, patient-centered environment. We offer mentors, modern therapies, and opportunities to advance clinically.